Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$234.96 - $292.55 $250,232 - $311,565
-1,065 Closed
0 $0
Q1 2022

May 03, 2022

BUY
$221.42 - $260.97 $235,812 - $277,933
1,065 New
1,065 $278,000
Q1 2021

May 27, 2021

SELL
$207.02 - $241.31 $610,087 - $711,140
-2,947 Closed
0 $0
Q4 2020

Feb 03, 2021

SELL
$207.01 - $276.09 $137,454 - $183,323
-664 Reduced 18.39%
2,947 $696,000
Q3 2020

Nov 09, 2020

BUY
$255.65 - $303.1 $923,152 - $1.09 Million
3,611 New
3,611 $983,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Jackson Creek Investment Advisors LLC Portfolio

Follow Jackson Creek Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.